| ESPERION THERAPEUTICS |
| USA |
| Gesundheit |
| US29664W1053 / A1W1SJ |
| 0ET (Frankfurt) / ESPR (NASDAQ) |
| FRA:0ET, ETR:0ET, 0ET:GR, NASDAQ:ESPR |
| - |
| https://www.esperion.com/ |
|
Esperion Therapeutics Inc. is a biopharmaceutical company committed to developing and commercializing innovative lipid-lowering therapies to address cardiovascular disease. Its primary focus is on cre..
>Volltext.. |
| 559.68 Mio. EUR |
| 992.7 Mio. EUR |
| 261.49 Mio. EUR |
| -25.22 Mio. EUR |
| -91.09 Mio. EUR |
| -0.46 EUR |
| 517.27 Mio. EUR |
| 79.57 Mio. EUR |
| -80.29 Mio. EUR |
| 0.26 |
| -2.43% |
| -15.73% |
| - |
| - |
| - |
| - |
| ESPERION |
| 10.03.26 |
|
||||
|